Day One Biopharmaceuticals Inc (DAWN) FY2025Q3 Earning Prediction
Day One Biopharmaceuticals Inc (DAWN) is set to release its earnings performance on 11/04 16:00:00 ET in After Hours trading. Consensus forecasts predict a revenue of 37.83M and an earnings per share (EPS) of -0.28 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
DAWN Transcript
The earnings call shows strong financial performance with a 15% QoQ revenue increase and an 89% YoY growth, alongside strategic product developments and expansion plans. Despite some uncertainties in data maturity and profitability guidance, the company's solid cash position and reduced operating expenses highlight financial discipline. The Q&A session reflects management's cautious optimism, with positive updates on trial progress and market expansion. Given the market cap of approximately $1.2 billion, the stock is likely to react positively, with potential gains in the 2% to 8% range over the next two weeks.
The earnings call highlights strong financial performance with a 10% increase in net product revenue and disciplined cost control. The Q&A section reveals positive sentiment towards new patient starts and physician confidence, supported by promising ASCO data. Despite some uncertainties in portfolio diversification and economic conditions, the company's strong cash position and strategic focus on OJEMDA provide a positive outlook. Given the market cap of $1.2 billion, the stock price is likely to see a positive movement of 2% to 8% over the next two weeks.
The earnings call indicates positive financial performance with net revenue growth and better-than-expected EPS. The cash position is strong with no debt, reducing financing risks. The Q&A session confirms steady patient adoption and management's confidence in market positioning. Despite competitive pressures and regulatory challenges, the company's strategic focus on pipeline expansion and business development is promising. The positive sentiment is tempered slightly by management's lack of clarity on certain trial details, but overall, the financial health and strategic initiatives suggest a positive stock price movement in the short term.
DAWN Slides
DAWN Report
Frequently Asked Questions
What is the Day One Biopharmaceuticals Inc FY2025Q3 Earnings Release Date and Time?
Day One Biopharmaceuticals Inc (DAWN) is scheduled to release its FY2025Q3 earnings report onNov 4, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Day One Biopharmaceuticals Inc FY2025Q3 Revenue and EPS?
Analysts' consensus predicts 37.83M in revenue and an EPS of -0.28 for Day One Biopharmaceuticals Inc's FY2025Q3.
What Does Intellectia's AI Predict for Day One Biopharmaceuticals Inc FY2025Q3 Earnings?
Intellectia's exclusive AI algorithms forecast a forDay One Biopharmaceuticals Inc's FY2025Q3 earnings, with a prediction date of Nov 4, 2025. Day One Biopharmaceuticals Inc
How Can I Use This Earnings Prediction to Trade DAWN Stock?
Leverage Intellectia's AI forecast to position trades ahead of theNov 4, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Day One Biopharmaceuticals Inc FY2025Q3?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
